Download PDF
July 6, 2017

IARC Will Convene Advisory Group in 2018/2019 to Consider Nominations

Lynn L. Bergeson Carla N. Hutton

To assist the International Agency for Research on Cancer (IARC) in selecting agents for review in future Monographs, IARC regularly convenes international, interdisciplinary Advisory Groups to review all public nominations and to recommend those it considers to be of high priority.  According to information on its website, IARC will convene its next Advisory Group in 2018/2019.  IARC encourages the general public, the scientific community, national health agencies, and other organizations to nominate agents for review in future IARC Monographs.  IARC states that nominations may include chemicals, mixtures, occupations, physical agents, biological agents, lifestyle factors, and anything else suspected of causing cancer in humans.  IARC will select agents for review based on:  (a) evidence of human exposure; and (b) evidence or suspicion of carcinogenicity.  IARC notes that in response to new scientific information or an urgent public health need, it may schedule nominated agents for review at any time.